Predictive values for different cancers and inflammatory bowel disease of 6 common abdominal symptoms among more than 1.9 million primary care patients in the UK: A cohort study.

<h4>Background</h4>The diagnostic assessment of abdominal symptoms in primary care presents a challenge. Evidence is needed about the positive predictive values (PPVs) of abdominal symptoms for different cancers and inflammatory bowel disease (IBD).<h4>Methods and findings</h4&g...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Annie Herbert, Meena Rafiq, Tra My Pham, Cristina Renzi, Gary A Abel, Sarah Price, Willie Hamilton, Irene Petersen, Georgios Lyratzopoulos
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Acceso en línea:https://doaj.org/article/92d6cbe036ca4e93b47b990f9143e4ed
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:92d6cbe036ca4e93b47b990f9143e4ed
record_format dspace
spelling oai:doaj.org-article:92d6cbe036ca4e93b47b990f9143e4ed2021-12-02T19:55:40ZPredictive values for different cancers and inflammatory bowel disease of 6 common abdominal symptoms among more than 1.9 million primary care patients in the UK: A cohort study.1549-12771549-167610.1371/journal.pmed.1003708https://doaj.org/article/92d6cbe036ca4e93b47b990f9143e4ed2021-08-01T00:00:00Zhttps://doi.org/10.1371/journal.pmed.1003708https://doaj.org/toc/1549-1277https://doaj.org/toc/1549-1676<h4>Background</h4>The diagnostic assessment of abdominal symptoms in primary care presents a challenge. Evidence is needed about the positive predictive values (PPVs) of abdominal symptoms for different cancers and inflammatory bowel disease (IBD).<h4>Methods and findings</h4>Using data from The Health Improvement Network (THIN) in the United Kingdom (2000-2017), we estimated the PPVs for diagnosis of (i) cancer (overall and for different cancer sites); (ii) IBD; and (iii) either cancer or IBD in the year post-consultation with each of 6 abdominal symptoms: dysphagia (n = 86,193 patients), abdominal bloating/distension (n = 100,856), change in bowel habit (n = 106,715), rectal bleeding (n = 235,094), dyspepsia (n = 517,326), and abdominal pain (n = 890,490). The median age ranged from 54 (abdominal pain) to 63 years (dysphagia and change in bowel habit); the ratio of women/men ranged from 50%:50% (rectal bleeding) to 73%:27% (abdominal bloating/distension). Across all studied symptoms, the risk of diagnosis of cancer and the risk of diagnosis of IBD were of similar magnitude, particularly in women, and younger men. Estimated PPVs were greatest for change in bowel habit in men (4.64% cancer and 2.82% IBD) and for rectal bleeding in women (2.39% cancer and 2.57% IBD) and lowest for dyspepsia (for cancer: 1.41% men and 1.03% women; for IBD: 0.89% men and 1.00% women). Considering PPVs for specific cancers, change in bowel habit and rectal bleeding had the highest PPVs for colon and rectal cancer; dysphagia for esophageal cancer; and abdominal bloating/distension (in women) for ovarian cancer. The highest PPVs of abdominal pain (either sex) and abdominal bloating/distension (men only) were for non-abdominal cancer sites. For the composite outcome of diagnosis of either cancer or IBD, PPVs of rectal bleeding exceeded the National Institute of Health and Care Excellence (NICE)-recommended specialist referral threshold of 3% in all age-sex strata, as did PPVs of abdominal pain, change in bowel habit, and dyspepsia, in those aged 60 years and over. Study limitations include reliance on accuracy and completeness of coding of symptoms and disease outcomes.<h4>Conclusions</h4>Based on evidence from more than 1.9 million patients presenting in primary care, the findings provide estimated PPVs that could be used to guide specialist referral decisions, considering the PPVs of common abdominal symptoms for cancer alongside that for IBD and their composite outcome (cancer or IBD), taking into account the variable PPVs of different abdominal symptoms for different cancers sites. Jointly assessing the risk of cancer or IBD can better support decision-making and prompt diagnosis of both conditions, optimising specialist referrals or investigations, particularly in women.Annie HerbertMeena RafiqTra My PhamCristina RenziGary A AbelSarah PriceWillie HamiltonIrene PetersenGeorgios LyratzopoulosPublic Library of Science (PLoS)articleMedicineRENPLoS Medicine, Vol 18, Iss 8, p e1003708 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
spellingShingle Medicine
R
Annie Herbert
Meena Rafiq
Tra My Pham
Cristina Renzi
Gary A Abel
Sarah Price
Willie Hamilton
Irene Petersen
Georgios Lyratzopoulos
Predictive values for different cancers and inflammatory bowel disease of 6 common abdominal symptoms among more than 1.9 million primary care patients in the UK: A cohort study.
description <h4>Background</h4>The diagnostic assessment of abdominal symptoms in primary care presents a challenge. Evidence is needed about the positive predictive values (PPVs) of abdominal symptoms for different cancers and inflammatory bowel disease (IBD).<h4>Methods and findings</h4>Using data from The Health Improvement Network (THIN) in the United Kingdom (2000-2017), we estimated the PPVs for diagnosis of (i) cancer (overall and for different cancer sites); (ii) IBD; and (iii) either cancer or IBD in the year post-consultation with each of 6 abdominal symptoms: dysphagia (n = 86,193 patients), abdominal bloating/distension (n = 100,856), change in bowel habit (n = 106,715), rectal bleeding (n = 235,094), dyspepsia (n = 517,326), and abdominal pain (n = 890,490). The median age ranged from 54 (abdominal pain) to 63 years (dysphagia and change in bowel habit); the ratio of women/men ranged from 50%:50% (rectal bleeding) to 73%:27% (abdominal bloating/distension). Across all studied symptoms, the risk of diagnosis of cancer and the risk of diagnosis of IBD were of similar magnitude, particularly in women, and younger men. Estimated PPVs were greatest for change in bowel habit in men (4.64% cancer and 2.82% IBD) and for rectal bleeding in women (2.39% cancer and 2.57% IBD) and lowest for dyspepsia (for cancer: 1.41% men and 1.03% women; for IBD: 0.89% men and 1.00% women). Considering PPVs for specific cancers, change in bowel habit and rectal bleeding had the highest PPVs for colon and rectal cancer; dysphagia for esophageal cancer; and abdominal bloating/distension (in women) for ovarian cancer. The highest PPVs of abdominal pain (either sex) and abdominal bloating/distension (men only) were for non-abdominal cancer sites. For the composite outcome of diagnosis of either cancer or IBD, PPVs of rectal bleeding exceeded the National Institute of Health and Care Excellence (NICE)-recommended specialist referral threshold of 3% in all age-sex strata, as did PPVs of abdominal pain, change in bowel habit, and dyspepsia, in those aged 60 years and over. Study limitations include reliance on accuracy and completeness of coding of symptoms and disease outcomes.<h4>Conclusions</h4>Based on evidence from more than 1.9 million patients presenting in primary care, the findings provide estimated PPVs that could be used to guide specialist referral decisions, considering the PPVs of common abdominal symptoms for cancer alongside that for IBD and their composite outcome (cancer or IBD), taking into account the variable PPVs of different abdominal symptoms for different cancers sites. Jointly assessing the risk of cancer or IBD can better support decision-making and prompt diagnosis of both conditions, optimising specialist referrals or investigations, particularly in women.
format article
author Annie Herbert
Meena Rafiq
Tra My Pham
Cristina Renzi
Gary A Abel
Sarah Price
Willie Hamilton
Irene Petersen
Georgios Lyratzopoulos
author_facet Annie Herbert
Meena Rafiq
Tra My Pham
Cristina Renzi
Gary A Abel
Sarah Price
Willie Hamilton
Irene Petersen
Georgios Lyratzopoulos
author_sort Annie Herbert
title Predictive values for different cancers and inflammatory bowel disease of 6 common abdominal symptoms among more than 1.9 million primary care patients in the UK: A cohort study.
title_short Predictive values for different cancers and inflammatory bowel disease of 6 common abdominal symptoms among more than 1.9 million primary care patients in the UK: A cohort study.
title_full Predictive values for different cancers and inflammatory bowel disease of 6 common abdominal symptoms among more than 1.9 million primary care patients in the UK: A cohort study.
title_fullStr Predictive values for different cancers and inflammatory bowel disease of 6 common abdominal symptoms among more than 1.9 million primary care patients in the UK: A cohort study.
title_full_unstemmed Predictive values for different cancers and inflammatory bowel disease of 6 common abdominal symptoms among more than 1.9 million primary care patients in the UK: A cohort study.
title_sort predictive values for different cancers and inflammatory bowel disease of 6 common abdominal symptoms among more than 1.9 million primary care patients in the uk: a cohort study.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/92d6cbe036ca4e93b47b990f9143e4ed
work_keys_str_mv AT annieherbert predictivevaluesfordifferentcancersandinflammatoryboweldiseaseof6commonabdominalsymptomsamongmorethan19millionprimarycarepatientsintheukacohortstudy
AT meenarafiq predictivevaluesfordifferentcancersandinflammatoryboweldiseaseof6commonabdominalsymptomsamongmorethan19millionprimarycarepatientsintheukacohortstudy
AT tramypham predictivevaluesfordifferentcancersandinflammatoryboweldiseaseof6commonabdominalsymptomsamongmorethan19millionprimarycarepatientsintheukacohortstudy
AT cristinarenzi predictivevaluesfordifferentcancersandinflammatoryboweldiseaseof6commonabdominalsymptomsamongmorethan19millionprimarycarepatientsintheukacohortstudy
AT garyaabel predictivevaluesfordifferentcancersandinflammatoryboweldiseaseof6commonabdominalsymptomsamongmorethan19millionprimarycarepatientsintheukacohortstudy
AT sarahprice predictivevaluesfordifferentcancersandinflammatoryboweldiseaseof6commonabdominalsymptomsamongmorethan19millionprimarycarepatientsintheukacohortstudy
AT williehamilton predictivevaluesfordifferentcancersandinflammatoryboweldiseaseof6commonabdominalsymptomsamongmorethan19millionprimarycarepatientsintheukacohortstudy
AT irenepetersen predictivevaluesfordifferentcancersandinflammatoryboweldiseaseof6commonabdominalsymptomsamongmorethan19millionprimarycarepatientsintheukacohortstudy
AT georgioslyratzopoulos predictivevaluesfordifferentcancersandinflammatoryboweldiseaseof6commonabdominalsymptomsamongmorethan19millionprimarycarepatientsintheukacohortstudy
_version_ 1718375853155418112